FDA Inspection 1254848 — Zhejiang Top Medicine Co., Ltd.
The FDA completed an inspection of Zhejiang Top Medicine Co., Ltd. on Oct 25, 2024 in Deqing, Huzhou. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Oct 25, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Deqing, Huzhou (China)